Tekturna Kidney Damage Warning Added to Labels in Europe
European drug regulators are calling for new kidney damage warnings for Tekturna and other drugs containing the active ingredient aliskiren.
European drug regulators are calling for new kidney damage warnings for Tekturna and other drugs containing the active ingredient aliskiren.
Potential concerns about side effects of Tekturna, a blood pressure drug sold by Novartis, have surfaced after clinical trials were canceled due to a high number of strokes and kidney…